Revance Therapeutics, Inc. - COM (RVNC)

Q3 2017 13F Holders as of 9/30/2017

Type / Class
Equity / COM
Number of holders
83
Total Shares
27.4M
Shares change
-80.5K
Total reported value, excl. options
$754M
Value change
-$1.52M
Put/Call ratio
1.06
Number of buys
40
Number of sells
-36
Price
$27.55
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.